Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Molecular properties of epithelial, amiloride-blockable Na+ channels.
Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients.
Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
Effectiveness of Natalizumab in Patients with Highly Active Relapsing Remitting Multiple Sclerosis.
The investigation of acute optic neuritis: a review and proposed protocol.
Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.
An observational study to assess persistence, adherence, quality of life, and treatment satisfaction in patients beginning therapy with the Avonex® PEN™ (PERSIST)
Gait variability measures reveal differences between multiple sclerosis patients and healthy controls.
The Submaximal Clinical Exercise Tolerance Test (SXTT) to Establish Safe Exercise Prescription Parameters for Patients with Chronic Disease and Disability.
Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression in Reactive Astrocytes.
Reduced serum orexin-A levels in autoimmune encephalitis and neuromyelitis optica patients.
Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis.
Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS.
Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.
A case of natalizumab-associated progressive multifocal leukoencephalopathy with repeated negative CSF JC virus testing.
Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis.
Changes to anti-JCV antibody levels in a Swedish national MS cohort.
Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system.
Galectin-1 for neuroprotection?
Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathy.
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients (TERI-PRO)
Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor.
The extent of ultrastructural spinal cord pathology reflects disease severity in experimental autoimmune encephalomyelitis.
Visual Functional and Histopathological Correlation in Experimental Autoimmune Optic Neuritis.
Pages
« first
‹ previous
…
140
141
142
143
144
145
146
147
148
…
next ›
last »